APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Analytical Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Analytical Testing Market Outlook and Growth Opportunities 2026

Report ID 17421415041 January 2026190 pages

Choose your research edition.

Industry ResearchPharmaceutical Analytical Testing Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Analytical Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Analytical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Analytical Testing Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Analytical Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pharmaceutical Analytical Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Analytical Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Analytical Testing market include Laboratory Testing, Eurofins Scientific, SGS SA, Intertek Phamaceutical Services, West Pharmaceutical Services, Toxikon, Pace Analytical Services, Boston Analytical and Steris, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Analytical Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Analytical Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Analytical Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Analytical Testing market.

Pharmaceutical Analytical Testing Segment by Company

Laboratory Testing

Eurofins Scientific

SGS SA

Intertek Phamaceutical Services

West Pharmaceutical Services

Toxikon

Pace Analytical Services

Boston Analytical

Steris

Catalent

Charles River Laboratories

Merck

Solvias

Pharmaceutical Analytical Testing Segment by Type

Bioanalytical Testing

Method Development & Validation

Stability Testing

Drug Substances Testing

Pharmaceutical Analytical Testing Segment by Application

Laboratory and Research Institutions

Pharmaceutical Center

Other

Pharmaceutical Analytical Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Analytical Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Analytical Testing key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Analytical Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Analytical Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Analytical Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Analytical Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Analytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Analytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Analytical Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Analytical Testing industry.

Chapter 3: Detailed analysis of Pharmaceutical Analytical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Analytical Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Analytical Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Analytical Testing Industry Trends Table 2. Pharmaceutical Analytical Testing Industry Drivers Table 3. Pharmaceutical Analytical Testing Industry Opportunities and Challenges Table 4. Pharmaceutical Analytical Testing Industry Restraints Table 5. Global Pharmaceutical Analytical Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Analytical Testing Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Analytical Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Analytical Testing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Analytical Testing Company, Product Type & Application Table 10. Global Pharmaceutical Analytical Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Analytical Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bioanalytical Testing Table 15. Significant Companies of Method Development & Validation Table 16. Significant Companies of Stability Testing Table 17. Significant Companies of Drug Substances Testing Table 18. Global Pharmaceutical Analytical Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Analytical Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Analytical Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Analytical Testing Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Analytical Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Laboratory and Research Institutions Table 24. Significant Companies of Pharmaceutical Center Table 25. Significant Companies of Other Table 26. Global Pharmaceutical Analytical Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Analytical Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Analytical Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Analytical Testing Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical Analytical Testing Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical Analytical Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Analytical Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Analytical Testing Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical Analytical Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Analytical Testing Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical Analytical Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Analytical Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Analytical Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical Analytical Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Analytical Testing Sales Value Market Share by Country (2027-2032) Table 41. Laboratory Testing Company Information Table 42. Laboratory Testing Business Overview Table 43. Laboratory Testing Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Laboratory Testing Pharmaceutical Analytical Testing Product Portfolio Table 45. Laboratory Testing Recent Development Table 46. Eurofins Scientific Company Information Table 47. Eurofins Scientific Business Overview Table 48. Eurofins Scientific Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Eurofins Scientific Pharmaceutical Analytical Testing Product Portfolio Table 50. Eurofins Scientific Recent Development Table 51. SGS SA Company Information Table 52. SGS SA Business Overview Table 53. SGS SA Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. SGS SA Pharmaceutical Analytical Testing Product Portfolio Table 55. SGS SA Recent Development Table 56. Intertek Phamaceutical Services Company Information Table 57. Intertek Phamaceutical Services Business Overview Table 58. Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Intertek Phamaceutical Services Pharmaceutical Analytical Testing Product Portfolio Table 60. Intertek Phamaceutical Services Recent Development Table 61. West Pharmaceutical Services Company Information Table 62. West Pharmaceutical Services Business Overview Table 63. West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. West Pharmaceutical Services Pharmaceutical Analytical Testing Product Portfolio Table 65. West Pharmaceutical Services Recent Development Table 66. Toxikon Company Information Table 67. Toxikon Business Overview Table 68. Toxikon Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Toxikon Pharmaceutical Analytical Testing Product Portfolio Table 70. Toxikon Recent Development Table 71. Pace Analytical Services Company Information Table 72. Pace Analytical Services Business Overview Table 73. Pace Analytical Services Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pace Analytical Services Pharmaceutical Analytical Testing Product Portfolio Table 75. Pace Analytical Services Recent Development Table 76. Boston Analytical Company Information Table 77. Boston Analytical Business Overview Table 78. Boston Analytical Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Boston Analytical Pharmaceutical Analytical Testing Product Portfolio Table 80. Boston Analytical Recent Development Table 81. Steris Company Information Table 82. Steris Business Overview Table 83. Steris Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Steris Pharmaceutical Analytical Testing Product Portfolio Table 85. Steris Recent Development Table 86. Catalent Company Information Table 87. Catalent Business Overview Table 88. Catalent Pharmaceutical Analytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Catalent Pharmaceutical Analytical Testing Product Portfolio Table 90. Catalent Recent Development Table 91. Charles River Laboratories Company Information Table 92. Charles River Laboratories Business Overview Table 93. Charles River Laboratories Pharmaceutical Analytical Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Charles River Laboratories Pharmaceutical Analytical Testing Product Portfolio Table 95. Charles River Laboratories Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Pharmaceutical Analytical Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck Pharmaceutical Analytical Testing Product Portfolio Table 100. Merck Recent Development Table 101. Solvias Company Information Table 102. Solvias Business Overview Table 103. Solvias Pharmaceutical Analytical Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Solvias Pharmaceutical Analytical Testing Product Portfolio Table 105. Solvias Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Pharmaceutical Analytical Testing Product Image Figure 2. Global Pharmaceutical Analytical Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Analytical Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Analytical Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bioanalytical Testing Image Figure 8. Method Development & Validation Image Figure 9. Stability Testing Image Figure 10. Drug Substances Testing Image Figure 11. Global Pharmaceutical Analytical Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Analytical Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Analytical Testing Sales Value Share by Type (2021-2032) Figure 14. Laboratory and Research Institutions Image Figure 15. Pharmaceutical Center Image Figure 16. Other Image Figure 17. Global Pharmaceutical Analytical Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Analytical Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Analytical Testing Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical Analytical Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical Analytical Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical Analytical Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Analytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical Analytical Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical Analytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical Analytical Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical Analytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical Analytical Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical Analytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical Analytical Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical Analytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Bioanalytical Testing
  • Method Development & Validation
  • Stability Testing
  • Drug Substances Testing
Applications
  • Laboratory and Research Institutions
  • Pharmaceutical Center
  • Other
Companies covered
  • Laboratory Testing
  • Eurofins Scientific
  • SGS SA
  • Intertek Phamaceutical Services
  • West Pharmaceutical Services
  • Toxikon
  • Pace Analytical Services
  • Boston Analytical
  • Steris
  • Catalent
  • Charles River Laboratories
  • Merck
  • Solvias

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Analytical Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Analytical Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Analytical Testing Market Dynamics
  1. 2.1 Pharmaceutical Analytical Testing Industry Trends
  2. 2.2 Pharmaceutical Analytical Testing Industry Drivers
  3. 2.3 Pharmaceutical Analytical Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Analytical Testing Industry Restraints
3 Pharmaceutical Analytical Testing Market by Company
  1. 3.1 Global Pharmaceutical Analytical Testing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Analytical Testing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Analytical Testing Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Analytical Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Analytical Testing Company Product Type and Application
  6. 3.6 Global Pharmaceutical Analytical Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Analytical Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Analytical Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Analytical Testing Market by Type
  1. 4.1 Pharmaceutical Analytical Testing Type Introduction
  2. 4.1.1 Bioanalytical Testing
  3. 4.1.2 Method Development & Validation
  4. 4.1.3 Stability Testing
  5. 4.1.4 Drug Substances Testing
  6. 4.2 Global Pharmaceutical Analytical Testing Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Analytical Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Analytical Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Analytical Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Analytical Testing Market by Application
  1. 5.1 Pharmaceutical Analytical Testing Application Introduction
  2. 5.1.1 Laboratory and Research Institutions
  3. 5.1.2 Pharmaceutical Center
  4. 5.1.3 Other
  5. 5.2 Global Pharmaceutical Analytical Testing Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Analytical Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Analytical Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Analytical Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Analytical Testing Regional Value Analysis
  1. 6.1 Global Pharmaceutical Analytical Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Analytical Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Analytical Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Analytical Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Analytical Testing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Analytical Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Analytical Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Analytical Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Analytical Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Analytical Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Analytical Testing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Analytical Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Analytical Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Analytical Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Analytical Testing Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Analytical Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Analytical Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Analytical Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Analytical Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Analytical Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Analytical Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Analytical Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Laboratory Testing
  2. 8.1.1 Laboratory Testing Company Information
  3. 8.1.2 Laboratory Testing Business Overview
  4. 8.1.3 Laboratory Testing Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Laboratory Testing Pharmaceutical Analytical Testing Product Portfolio
  6. 8.1.5 Laboratory Testing Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Pharmaceutical Analytical Testing Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 SGS SA
  14. 8.3.1 SGS SA Company Information
  15. 8.3.2 SGS SA Business Overview
  16. 8.3.3 SGS SA Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SGS SA Pharmaceutical Analytical Testing Product Portfolio
  18. 8.3.5 SGS SA Recent Developments
  19. 8.4 Intertek Phamaceutical Services
  20. 8.4.1 Intertek Phamaceutical Services Company Information
  21. 8.4.2 Intertek Phamaceutical Services Business Overview
  22. 8.4.3 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Product Portfolio
  24. 8.4.5 Intertek Phamaceutical Services Recent Developments
  25. 8.5 West Pharmaceutical Services
  26. 8.5.1 West Pharmaceutical Services Company Information
  27. 8.5.2 West Pharmaceutical Services Business Overview
  28. 8.5.3 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 West Pharmaceutical Services Pharmaceutical Analytical Testing Product Portfolio
  30. 8.5.5 West Pharmaceutical Services Recent Developments
  31. 8.6 Toxikon
  32. 8.6.1 Toxikon Company Information
  33. 8.6.2 Toxikon Business Overview
  34. 8.6.3 Toxikon Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toxikon Pharmaceutical Analytical Testing Product Portfolio
  36. 8.6.5 Toxikon Recent Developments
  37. 8.7 Pace Analytical Services
  38. 8.7.1 Pace Analytical Services Company Information
  39. 8.7.2 Pace Analytical Services Business Overview
  40. 8.7.3 Pace Analytical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pace Analytical Services Pharmaceutical Analytical Testing Product Portfolio
  42. 8.7.5 Pace Analytical Services Recent Developments
  43. 8.8 Boston Analytical
  44. 8.8.1 Boston Analytical Company Information
  45. 8.8.2 Boston Analytical Business Overview
  46. 8.8.3 Boston Analytical Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Analytical Pharmaceutical Analytical Testing Product Portfolio
  48. 8.8.5 Boston Analytical Recent Developments
  49. 8.9 Steris
  50. 8.9.1 Steris Company Information
  51. 8.9.2 Steris Business Overview
  52. 8.9.3 Steris Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Steris Pharmaceutical Analytical Testing Product Portfolio
  54. 8.9.5 Steris Recent Developments
  55. 8.10 Catalent
  56. 8.10.1 Catalent Company Information
  57. 8.10.2 Catalent Business Overview
  58. 8.10.3 Catalent Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Catalent Pharmaceutical Analytical Testing Product Portfolio
  60. 8.10.5 Catalent Recent Developments
  61. 8.11 Charles River Laboratories
  62. 8.11.1 Charles River Laboratories Company Information
  63. 8.11.2 Charles River Laboratories Business Overview
  64. 8.11.3 Charles River Laboratories Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Charles River Laboratories Pharmaceutical Analytical Testing Product Portfolio
  66. 8.11.5 Charles River Laboratories Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Pharmaceutical Analytical Testing Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Solvias
  74. 8.13.1 Solvias Company Information
  75. 8.13.2 Solvias Business Overview
  76. 8.13.3 Solvias Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Solvias Pharmaceutical Analytical Testing Product Portfolio
  78. 8.13.5 Solvias Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst